Understanding the HER2 Story in Gastrointestinal Malignancies: A GEA and BTC Focus
We've collaborated with Medscape Oncology Global and Hope for Stomach Cancer to present a CME opportunity for health care professionals seeking to gain a better understanding of emerging anti-human epidermal growth factor receptor 2 (HER2) therapies used to manage gastroesophageal adenocarcinoma (GEA) and biliary tract cancer (BTC). Register and attend today.
